Hologic Announces Financial Results for Second Quarter Fiscal 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Hologic (HOLX) PT Boosted to $37 at Leerink Partners Amid 'Strong' Q2
April 30, 2015 6:33 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on Hologic (NASDAQ: HOLX) to $37.00 (from $34.00) following "strong" Q2 results.
commented, "HOLX delivered a strong F2Q led by solid tomo sales (now ~1800 placements in US) and strength in... More
Hologic (HOLX) Tops Q2 EPS by 2c, Raises FY15 Guidance
April 29, 2015 5:04 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $655.5 million versus the consensus estimate of $646.49 million.
Hologic sees FY2015 EPS of $1.57-$1.59, versus prior guidance of $1.54-$1.57 and the consensus of $1.57. Hologic... More
